Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial

C. Gridelli, F. Perrone, S. Palmeri, M. D'Aprile, F. Cognetti, A. Rossi, V. Gebbia, R. Pepe, E. Veltri, G. Airoma, A. Russo, P. Incoronato, A. F. Scinto, G. Palazzolo, M. Natali, V. Leonardi, C. Gallo, S. De Placido, A. R. Bianco

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences